Veterinary Medicines

Zycortal 25 mg/ml - Prolonged-release suspension for injection

Authorised
  • Desoxycortone pivalate
Download as PDF

Product identification

Medicine name:
Zycortal 25 mg/ml - Prolonged-release suspension for injection
Active substance:
  • Desoxycortone pivalate
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Desoxycortone pivalate
    25.00
    milligram(s)
    /
    1.00
    Vial
Pharmaceutical form:
  • Prolonged-release suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AA03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Vial (glass), Package_size:1 vial, Content:4 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dales Pharmaceuticals Limited
  • Eurovet Animal Health B.V.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 23/11/2022
Download
Bulgarian (PDF)
Published on: 23/11/2022
Download
Croatian (PDF)
Published on: 23/11/2022
Download
Czech (PDF)
Published on: 23/11/2022
Download
Danish (PDF)
Published on: 23/11/2022
Download
Dutch (PDF)
Published on: 23/11/2022
Download
Estonian (PDF)
Published on: 23/11/2022
Download
Finnish (PDF)
Published on: 23/11/2022
Download
French (PDF)
Published on: 23/11/2022
Download
German (PDF)
Published on: 23/11/2022
Download
Greek (PDF)
Published on: 23/11/2022
Download
Hungarian (PDF)
Published on: 23/11/2022
Download
Icelandic (PDF)
Published on: 23/11/2022
Download
Italian (PDF)
Published on: 23/11/2022
Download
Latvian (PDF)
Published on: 23/11/2022
Download
Lithuanian (PDF)
Published on: 23/11/2022
Download
Maltese (PDF)
Published on: 23/11/2022
Download
Norwegian (PDF)
Published on: 23/11/2022
Download
Polish (PDF)
Published on: 23/11/2022
Download
Portuguese (PDF)
Published on: 23/11/2022
Download
Romanian (PDF)
Published on: 23/11/2022
Download
Slovak (PDF)
Published on: 23/11/2022
Download
Slovenian (PDF)
Published on: 23/11/2022
Download
Spanish (PDF)
Published on: 23/11/2022
Download
Swedish (PDF)
Published on: 23/11/2022
Download

ema-puar-zycortal-v-3782-par-en.pdf

English (PDF)
Published on: 16/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."